Chris Parry

Vext Science (VEXT.C) seizes the opportunity in Arizona

“Medical marijuana dispensary owners who opted to expand into the adult-use market largely would do so in their existing physical locations,” stated The Phoenix New Times, “adding new staff and providing separate sales counters for medical and retail customers.”

Read More »

Vext Science (VEXT.C) cannabis chart defies gravity

“The core business, which is derived from an Arizona licensed vertically integrated model, generated USD $13 million in revenues during the first two quarters of 2019,” confirmed Equity Guru’s Sam Bourgi last October.

Ironically, VEXT is a healthy cannabis business, and investors are quickly gaining confidence in it.

Read More »

Equity.Guru podcast: Mistakes were made – Jeanette VanderMarel’s happy goodbye to Beleave (BE.C)

With the twitter announcement this morning that Jeanette had “happily” left the position of CEO at Beleave Kannabis (BE.C), Equity.Guru’s own Chris Parry was chomping at the bit to find out just what “happily” meant for the market and investors. Twenty minutes after making her announcement, VanderMarel phoned up Chris to give him the skinny on her decision as well as some explanations for past actions which gave both industry players and investors some pause.

Read More »

Equity Guru Podcasts